As of Feb 09
| -0.13 / -0.14%|
The 24 analysts offering 12-month price forecasts for Zimmer Biomet Holdings Inc have a median target of 121.50, with a high estimate of 150.00 and a low estimate of 92.00. The median estimate represents a +32.21% increase from the last price of 91.90.
The current consensus among 30 polled investment analysts is to Buy stock in Zimmer Biomet Holdings Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.